Apolipoprotein L1
-
Subject Areas on Research
- A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
- APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
- APOL1 Kidney Risk Variants and Cardiovascular Disease: An Individual Participant Data Meta-Analysis.
- APOL1 Nephrotoxicity: What Does Ion Transport Have to Do With It?
- APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases.
- APOL1 risk alleles among individuals with CKD in Northern Tanzania: A pilot study.
- APOL1 variants in HIV-associated nephropathy: just one piece of the puzzle.
- APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
- APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.
- APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.
- APOL1: a case in point for replacing race with genetics.
- Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.
- Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation.
- Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes.
- Effect of Genetic African Ancestry on eGFR and Kidney Disease.
- Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
- Genetic Basis of Health Disparity in Childhood Nephrotic Syndrome.
- HLA-DQA1 and APOL1 as Risk Loci for Childhood-Onset Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome.
- Host APOL1 genotype is independently associated with proteinuria in HIV infection.
- In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress.
- Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects.
- MYH9 and APOL1 are both associated with sickle cell disease nephropathy.
- Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study.
- RNA sequencing of isolated cell populations expressing human APOL1 G2 risk variant reveals molecular correlates of sickle cell nephropathy in zebrafish podocytes.